Zoetis Inc (ZTS) Stock Forecast
US · Healthcare
Current price
$77.82
Market cap
$32.62B
Mean price target
$124.59
Implied upside
60.1%
Key takeaways
- Analysts rate Zoetis Inc a “Buy”, with a mean price target of $124.59 — about 60.1% upside from the current $77.82, based on 17 analysts.
- ZTS is trading near its 52-week low, at 6% of the $72.38–$161.77 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 17 |
| Mean target | $124.59 |
| High target | $160.00 |
| Low target | $90.00 |
| Rating split (SB / B / H / S / SS) | 3 / 8 / 9 / 0 / 0 |
Price & trading
| Current price | $77.82 |
|---|---|
| Previous close | $78.17 |
| 52-week high | $161.77 |
| 52-week low | $72.38 |
| 50-day average | $91.79 |
| Beta | 0.74 |
See the full ZTS breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Zoetis Inc (ZTS) share price?
- Zoetis Inc last traded at $77.82 with a market capitalisation of about $32.6B.
- What is the analyst price target for ZTS?
- The mean analyst price target for Zoetis Inc is $124.59, roughly 60.1% above the latest price. The current consensus rating is “Buy”.
- Where can I see Zoetis Inc's full financial metrics?
- Luminoso tracks ZTS's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.